Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Maharashtra FDA cancels Johnson & Johnson baby powder manufacturing license

by AIP Online Bureau | Sep 17, 2022 | Health, Indian News, Policy, Regulation

The press note said that the samples of Johnson’s Baby Powder were declared “Not of Standard Quality”. FDA Maharashtra had taken the samples of Johnson’s Baby Powder at Pune and Nashik for quality check purposes Mumbai: Food & Drugs...
Next Entries »

Recent Posts

  • DGCA asks airlines to avoid 9 West Asia airspaces, restrict flying below 32,000 feet
  • Tariff refund lawsuits surge amid uncertainty about US plans
  • West Asia crisis impact limited so far, but risks rise if Strait disruption prolongs: Jefferies
  • Global trade growth likely to slow down to 1.9 pc this year amid West Asia crisis WTO
  • Wildfires, storms, floods contribute to record 92% of global insured losses in 2025:Swiss Re

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy